Maryland Avandia Lawyers Continue to Review Lawsuits

February 22, 2010 by  
Filed under Blog

A new Senate report suggests that GlaxoSmithKline PLC has been well aware of the Avandia heart attack risks, but fought to keep the drug on the market, causing hundreds of users to suffer a heart attack or congestive heart failure that may have been avoided by taking another diabetes drug. Read more